Clinical Trials Directory

Trials / Completed

CompletedNCT04457063

Endothelial Cell Loss After Penetrating Keratoplasty

Endothelial Cell Loss Following Toric ICL Implantation for Correction of Myopia and Astigmatism After Penetrating Keratoplasty

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Alexandria University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.

Detailed description

Penetrating keratoplasty (PKP) is considered a safe and effective procedure.This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.

Conditions

Interventions

TypeNameDescription
PROCEDUREPKP1. The horizontal axis was marked with a pointed marker at the slit lamp immediately before surgery. 2. TICL loading into the STAAR injector cartridge 3. Temporal clear corneal 3 mm incision \& 2-side ports then viscoelastic injection into the AC 4. Implantation of the TICL using the injector, then rotation according to the implantation diagram guided with Mendez protractor, and lastly placement of the haptics under the iris. 5. Pupil constriction with A.Ch. 6. Washing the viscoelastic \&Wound hydration. 7. Topical antibiotic steroids (Vigamox and Tobradex) 4 times /day for 3weeks

Timeline

Start date
2018-07-01
Primary completion
2020-06-01
Completion
2020-06-15
First posted
2020-07-07
Last updated
2020-07-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04457063. Inclusion in this directory is not an endorsement.